Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Shares Outstanding (Diluted Average): 2020-2023

Historic Shares Outstanding (Diluted Average) for Solid Biosciences (SLDB) over the last 4 years, with Dec 2023 value amounting to $19.9 million.

  • Solid Biosciences' Shares Outstanding (Diluted Average) rose 106.60% to $41.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $41.4 million, marking a year-over-year increase of 106.60%. This contributed to the annual value of $19.9 million for FY2023, which is 133.60% up from last year.
  • Solid Biosciences' Shares Outstanding (Diluted Average) amounted to $19.9 million in FY2023, which was up 133.60% from $8.5 million recorded in FY2022.
  • In the past 5 years, Solid Biosciences' Shares Outstanding (Diluted Average) registered a high of $19.9 million during FY2023, and its lowest value of $3.5 million during FY2020.
  • Over the past 3 years, Solid Biosciences' median Shares Outstanding (Diluted Average) value was $8.5 million (recorded in 2022), while the average stood at $11.8 million.
  • Data for Solid Biosciences' Shares Outstanding (Diluted Average) shows a peak YoY spiked of 133.60% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Solid Biosciences' Shares Outstanding (Diluted Average) stood at $3.5 million in 2020, then soared by 105.58% to $7.1 million in 2021, then increased by 19.58% to $8.5 million in 2022, then surged by 133.60% to $19.9 million in 2023.